Passa ai contenuti principali

Fuyao Glass America will pay $100,000 in penalties for violating workplace safety regulations.


THOMAS GNAU/STAFF






Fuyao Glass America will pay $100,000 in penalties for violating workplace safety regulations.
Fuyao has entered a settlement agreement with the Occupational Safety and Health Administration, after initially being fined nearly $227,000 in penalties last November. The U.S. Department of Labor’s watchdog office provided this news outlet with a copy of the settle agreement.
The company, which has a plant in Moraine, was issued penalties for multiple machine safety violations, some of which exposed workers to the threat of amputation and other serious injuries.
The settlement agreement is effective April 1, and stipulates that Fuyao will pay $100,000 in penalties in four equal payments of $25,000 each. The company will also have quarterly meetings for the next 12 months with OSHA to discuss the status of Fuyao’s compliance.
The settlement also outlines other actions Fuyao will take in coming months, including:
• The company will develop and maintain a safety and health management program that will “provide for the systematic identification, evaluation and prevention or control of workplace health and safety hazards.”
• Fuyao will reiterate during orientations, daily briefs and training events that an employee has the right to refuse to perform work that they believe is “unsafe or unhealthful without fear of discipline or other form of reprisal.”
• A “safety stand-down” will occur on or before May 1. That means work will be suspended so that the company can conduct activities related to improving health and safety at the facility. That includes a discussion by management of the importance of health with an emphasis on hazards related to falls, control of hazardous energy and machine guarding.
• A helpline program will be initiated that allows employees to report potential health and safety concerns by calling a designated phone number. The employee can remain anonymous.
The settlement agreement will still need to be signed by an administrative law judge, per OSHA guidelines. A representative of Fuyao also said the 28 proposed serious violations to 10 serious violations.

“Over the past year, our team of health and safety professionals — including nurses, specialists, engineers and outside contractors — have worked tirelessly to develop innovative safety solutions,” said Jeff Daochuan Liu, president of Fuyao Glass America Inc. “We are committed to maintaining a safe working environment for our employees.”

Commenti

Post popolari in questo blog

World Health Day today focuses on mental well-being

World Health Day today focuses on mental well-being ·                                  By Scott Scanlon ·                                  Published   Fri, Apr 7, 2017 By Sarah K. Martin – Contributing writer What does it mean to be healthy? For some people, health means having a strong body, free of  disease. Others may consider a creative mind to be a strong  indicator of health. Still others may think the greatest  determinant is a happy, fulfilling life. Whatever your definition, most people agree that “health”  has a mental component. The World Health Organization  (WHO) defines health as “a sta...

BIOCIDES and THYROID CANCER

The association between  occupational exposure to biocides and pesticides through a job-exposure matrix and thyroid cancer was examined by some researchers using data from a population-based case-control study involving 462 incident thyroid cancer cases and 498 controls in Connecticut collected in 2010-2011. It was observed that individuals ever-exposed to biocides had a high risk of thyroid cancer  ( OR=2.18, 95% Cl 1.28 to 3.73) No significant association between occupational exposure and cancer was found.

Is Botox able to help with depression? Consequently used for Occupational Medicine ?

·                                    Is Botox able to help with depression? Consequently used for Occupational Medicine ? The idea that Botox (botulinum toxin A) could help with  depression is being explored by, Allergan, despite the latest  trial showing patchy results. Based on the “facial feedback” hypothesis, which holds that  facial movement can influence emotional experience,  Allegan  is hopeful the drug’s anti-wrinkle and anti-frowning  formula can  be used to improve mood. Anecdotal evidence suggests Botox is already used off-label  for this purpose. Yet results from a phase II study of almost 260 patients show  that Botox is unable to meaningfully reduce depression after  six weeks compared with placebo. ...